832 related articles for article (PubMed ID: 25160573)
1. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
[TBL] [Abstract][Full Text] [Related]
2. Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease.
Doria JG; Silva FR; de Souza JM; Vieira LB; Carvalho TG; Reis HJ; Pereira GS; Dobransky T; Ribeiro FM
Br J Pharmacol; 2013 Jun; 169(4):909-21. PubMed ID: 23489026
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate receptor 5 as a potential therapeutic target in Huntington's disease.
Ribeiro FM; Hamilton A; Doria JG; Guimaraes IM; Cregan SP; Ferguson SS
Expert Opin Ther Targets; 2014 Nov; 18(11):1293-304. PubMed ID: 25118797
[TBL] [Abstract][Full Text] [Related]
4. The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's disease.
Doria JG; de Souza JM; Silva FR; Olmo IG; Carvalho TG; Alves-Silva J; Ferreira-Vieira TH; Santos JT; Xavier CQS; Silva NC; Maciel EMA; Conn PJ; Ribeiro FM
J Neurochem; 2018 Oct; 147(2):222-239. PubMed ID: 30028018
[TBL] [Abstract][Full Text] [Related]
5. A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's disease.
Simmons DA; Belichenko NP; Yang T; Condon C; Monbureau M; Shamloo M; Jing D; Massa SM; Longo FM
J Neurosci; 2013 Nov; 33(48):18712-27. PubMed ID: 24285878
[TBL] [Abstract][Full Text] [Related]
6. Caspase-6 activity in a BACHD mouse modulates steady-state levels of mutant huntingtin protein but is not necessary for production of a 586 amino acid proteolytic fragment.
Gafni J; Papanikolaou T; Degiacomo F; Holcomb J; Chen S; Menalled L; Kudwa A; Fitzpatrick J; Miller S; Ramboz S; Tuunanen PI; Lehtimäki KK; Yang XW; Park L; Kwak S; Howland D; Park H; Ellerby LM
J Neurosci; 2012 May; 32(22):7454-65. PubMed ID: 22649225
[TBL] [Abstract][Full Text] [Related]
7. Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington's disease.
Ribeiro FM; Devries RA; Hamilton A; Guimaraes IM; Cregan SP; Pires RG; Ferguson SS
Hum Mol Genet; 2014 Apr; 23(8):2030-42. PubMed ID: 24282028
[TBL] [Abstract][Full Text] [Related]
8. Huntington's disease and Group I metabotropic glutamate receptors.
Ribeiro FM; Pires RG; Ferguson SS
Mol Neurobiol; 2011 Feb; 43(1):1-11. PubMed ID: 21153060
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus.
Uslaner JM; Parmentier-Batteur S; Flick RB; Surles NO; Lam JS; McNaughton CH; Jacobson MA; Hutson PH
Neuropharmacology; 2009; 57(5-6):531-8. PubMed ID: 19627999
[TBL] [Abstract][Full Text] [Related]
10. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease.
Rocher AB; Gubellini P; Merienne N; Boussicault L; Petit F; Gipchtein P; Jan C; Hantraye P; Brouillet E; Bonvento G
Neurobiol Dis; 2016 Feb; 86():131-9. PubMed ID: 26626081
[TBL] [Abstract][Full Text] [Related]
11. A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mouse models of Alzheimer's disease.
Bellozi PMQ; Gomes GF; da Silva MCM; Lima IVA; Batista CRÁ; Carneiro Junior WO; Dória JG; Vieira ÉLM; Vieira RP; de Freitas RP; Ferreira CN; Candelario-Jalil E; Wyss-Coray T; Ribeiro FM; de Oliveira ACP
Neuropharmacology; 2019 Dec; 160():107785. PubMed ID: 31541651
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of apoptosis signal-regulating kinase 1 reduces endoplasmic reticulum stress and nuclear huntingtin fragments in a mouse model of Huntington disease.
Cho KJ; Lee BI; Cheon SY; Kim HW; Kim HJ; Kim GW
Neuroscience; 2009 Nov; 163(4):1128-34. PubMed ID: 19646509
[TBL] [Abstract][Full Text] [Related]
13. Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.
Spampanato J; Gu X; Yang XW; Mody I
Neuroscience; 2008 Dec; 157(3):606-20. PubMed ID: 18854207
[TBL] [Abstract][Full Text] [Related]
14. Cognitive Dysfunction in Huntington's Disease: Humans, Mouse Models and Molecular Mechanisms.
Giralt A; Saavedra A; Alberch J; Pérez-Navarro E
J Huntingtons Dis; 2012; 1(2):155-73. PubMed ID: 25063329
[TBL] [Abstract][Full Text] [Related]
15. mGluR5 antagonism increases autophagy and prevents disease progression in the
Abd-Elrahman KS; Hamilton A; Hutchinson SR; Liu F; Russell RC; Ferguson SSG
Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259100
[TBL] [Abstract][Full Text] [Related]
16. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
McBride JL; Ramaswamy S; Gasmi M; Bartus RT; Herzog CD; Brandon EP; Zhou L; Pitzer MR; Berry-Kravis EM; Kordower JH
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9345-50. PubMed ID: 16751280
[TBL] [Abstract][Full Text] [Related]
17. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice.
Horio M; Fujita Y; Hashimoto K
Fundam Clin Pharmacol; 2013 Oct; 27(5):483-8. PubMed ID: 22594375
[TBL] [Abstract][Full Text] [Related]
19. Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice.
Lee J; Kosaras B; Del Signore SJ; Cormier K; McKee A; Ratan RR; Kowall NW; Ryu H
Acta Neuropathol; 2011 Apr; 121(4):487-98. PubMed ID: 21161248
[TBL] [Abstract][Full Text] [Related]
20. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
